Document is current

Article History

Received: 25 March 2020

Accepted: 22 July 2020

First Online: 2 August 2020

Compliance with ethical standards

:

: ARB was recipient of a CAPES/Alexander von Humboldt fellowship award for experienced researchers and received speakers’ fee from Neurocademy GmBH (Munich, Germany). ARB is sponsored by the Brazilian National Scientific Fund (CNPq-1B) and the Academic Productivity Program (PIPA-A) from the Faculdade de Medicina da UNiversidade de São Paulo. ARB is also medical advisor of Flow Neuroscience and has a small equity of Flow. The work of L.B. is part of a PhD/residency program of the Ludwig-Maximilians University (LMU) and the International Max Planck Research School for Translational Psychiatry (IMPRS-TP) financially supported by the Else Kröner Fresenius Foundation. AT was supported by the Lundbeck foundation (Grant no. R244-2017-196), and the Novo Nordisk foundation (Grant no. NNF14OC0011413). FP is a member of the European Scientific Advisory Board of Brainsway Inc., Jerusalem, Israel, and has received speaker’s honoraria from Mag&More GmbH and the neuroCare Group. His lab has received support with equipment from neuroConn GmbH, Ilmenau, Germany, and Mag&More GmbH and Brainsway Inc., Jerusalem, Israel. This work was also supported by the German Center for Brain Stimulation (GCBS) research consortium (Work Package 5) [Grant no. 01EE1403E], funded by the Federal Ministry of Education and Research (BMBF).